Manufacturing Wire

The headline reports on a market study covering edge sensors, including analysis, forecasts, market size, trends, and insights.

The headline reports a Q&A with Ryan Last on reshoring pharma and biotech manufacturing ahead of tariff deadlines this summer.

The headline reports that operating panels market growth is expected to accelerate by 2035 amid Industry 4.0 adoption.

The headline frames American enterprise across a 250-year history and argues that its best work remains ahead.

The headline reports a global market analysis for bench instruments, including forecast, size, trends, and insights. It does not identify a specific company, facility, or transaction.

Douglas Brown’s The Black Book of Reshoring was named a finalist in the Business category of the 2026 International Book Awards.

The headline reports on United States industrial stocks positioned as ones to watch for July 2026, in the context of automation and robotics.

Industrial robotics is shifting toward physical AI and real-world deployment. The headline indicates a move from concept-oriented robotics toward systems intended for practical use.

Industrial robotics is being described as the proving ground for physical AI.

The headline reports that AI deals and embodied robotics are pushing factory automation into a new era.

The headline reports on realistic timelines for reshoring pharmaceutical manufacturing.

The headline reports on robotics companies that are transforming the industry in 2026.

The headline reports a busy week for industrial automation, including fenceless robots, humanoid IPOs, and a $100M expansion.

The headline reports that a U.S. robotics rebound, defense capacity buildout, and AI partnerships are defining manufacturing in mid-2026.

The headline reports that the U.S. reshoring story is moving from promise toward progress and is finding cyclical footing.

The headline says top robotics companies are transforming the industry in 2026.

The headline reports that Japan is targeting a sovereign AI model and 10 million robots.

The headline reports that Gerren McHam is discussing the future of U.S. pharma reshoring.

Lovesac is reshoring production of its Sactionals to the United States in 2026.

China’s humanoid robots have drawn global attention, but an emerging rental market is revealing limits in their practical use.